Role of elevated pressure in TRAIL-induced apoptosis in human lung carcinoma cells

被引:0
作者
Sangnam Oh
Daeho Kwon
Hyun Jeong Lee
Joonhee Kim
Eunil Lee
机构
[1] Cellular and Developmental Biology,Department of Preventive Medicine and Medical Research Center for Environmental Toxico
[2] Division of Biomedical Science,Genomics and Proteomics, College of Medicine
[3] Korea University,Avian Disease Laboratory, College of Veterinary Medicine
[4] Konkuk University,undefined
来源
Apoptosis | 2010年 / 15卷
关键词
Elevated pressure; TNF-related apoptosis-inducing ligand (TRAIL); Apoptosis; Cancer therapy;
D O I
暂无
中图分类号
学科分类号
摘要
TNF-related apoptosis-inducing ligand (TRAIL, Apo2L) is a promising anticancer agent with high specificity for cancer cells. Many strategies have been proposed to enhance the sensitivity of cancer cells to TRAIL-mediated apoptosis, including the use of combination treatment with conventional cancer therapies. However, few reports have evaluated the effects of TRAIL in combination with mechanical stress, which can also cause apoptosis of cancer cells. In the present study, we describe a custom-designed culture system that delivers two atmospheres of elevated pressure (EP) by using compressed air, and which enhances the sensitivity of cancer cells to TRAIL-mediated apoptosis. The combination of TRAIL and EP significantly increased apoptosis of human H460 lung cancer cells more than hyperbaric normoxia or normobaric mild hyperoxia. EP-potentiating TRAIL-mediated apoptosis of H460 cells was accompanied by up-regulated death receptor 5 (DR5), activation of caspases, decreased mitochondrial membrane potential, and reactive oxygen species production. We also observed EP-induced sensitization of TRAIL-mediated apoptosis in other cancer cell types. In contrast, human normal cells showed no DNA damage or cell death when exposed to the combined treatment. In a chicken chorioallantoic membrane model, EP enhanced TRAIL-mediated apoptosis of tumors that developed from transplanted H460 cells. Collectively, EP enhanced TRAIL-induced apoptosis of human lung carcinoma cells in vitro and in vivo. These findings suggest that EP is a mechanical and physiological stimulus that might have utility as a sensitizing tool for cancer therapy.
引用
收藏
页码:1517 / 1528
页数:11
相关论文
共 267 条
  • [1] Ferreira CG(2002)Apoptosis: target of cancer therapy Clin Cancer Res 8 2024-2034
  • [2] Epping M(1999)The TRAIL to selective tumor death Nat Med 5 146-147
  • [3] Kruyt FA(2000)Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 Immunity 12 611-620
  • [4] Giaccone G(2001)TRAIL/Apo-2L: mechanisms and clinical applications in cancer Neoplasia 3 535-546
  • [5] French LE(2008)The TRAIL apoptotic pathway in cancer onset, progression and therapy Nat Rev Cancer 8 782-798
  • [6] Tschopp J(2007)Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells Oncogene 27 3134-3144
  • [7] Kischkel FC(2009)Proteolytic Cleavage of p70 Ribosomal S6 Kinase by Caspase-3 during DNA damage-induced apoptosis Biochemistry 48 1474-1480
  • [8] Lawrence DA(2007)TRAIL therapy in non small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib Mol Cancer Ther 6 2103-2112
  • [9] Chuntharapai A(2009)Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib Mol Cancer Ther 8 292-302
  • [10] Schow P(2000)The Caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand Cancer Res 60 6259-6265